Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04884477 · ClinicalTrials.gov registry record
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
A clinical trial of COVID-19 and Convalescent Plasma, sponsored by Mayo Clinic.
- Completed
- Registry status
- 342
- Enrollment target
- 1
- Study location
NCT04884477 is a study of COVID-19 and Convalescent Plasma that has completed, run by Mayo Clinic. The registered enrollment target is 342 participants, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04884477, a study of COVID-19 and Convalescent Plasma, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 342 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to determine if patients with compromised B-cell function due to anti-CD20 therapy and newly diagnosed COVID-19 infection benefit from convalescent plasma.
Conditions Studied
Interventions
- BIOLOGICAL Convalescent Plasma
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 342 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2023-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04884477
The ClinicalTrials.gov registry entry for NCT04884477 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Convalescent Plasma is the first listed.
NCT04884477 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04884477 about?
NCT04884477 is a clinical study titled "COVID-19 Infection in Patients Receiving Anti-CD20 Therapy". This study is being conducted to determine if patients with compromised B-cell function due to anti-CD20 therapy and newly diagnosed COVID-19 infection benefit from convalescent plasma.
What is the current status of trial NCT04884477?
This trial is currently completed. The enrollment target is 342 participants. The study started on 2021-06-01. Estimated completion is 2023-01-15.
What conditions does trial NCT04884477 study?
This clinical trial studies the following conditions: COVID-19, Convalescent Plasma, Immunosuppressed Host, Anti-CD20 Therapy.
What interventions are being tested in trial NCT04884477?
The interventions under investigation include: Convalescent Plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT04884477?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04884477 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.